Cargando…

Whole Genome Sequencing in Cancer Clinics

Detalles Bibliográficos
Autores principales:	Chen, Ken, Meric-Bernstam, Funda
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2014
Materias:	Commentary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4484824/ https://www.ncbi.nlm.nih.gov/pubmed/26137530 http://dx.doi.org/10.1016/j.ebiom.2014.12.007

Ejemplares similares

Personalized cancer therapy—leveraging a knowledge base for clinical decision-making
por: Dumbrava, Ecaterina Ileana, et al.
Publicado: (2018)

ClinSeK: a targeted variant characterization framework for clinical sequencing
por: Zhou, Wanding, et al.
Publicado: (2015)

Targeting translation initiation in breast cancer
por: Akcakanat, Argun, et al.
Publicado: (2014)

Reconstructing mutational lineages in breast cancer by multi-patient-targeted single-cell DNA sequencing
por: Leighton, Jake, et al.
Publicado: (2022)

Cryptococcus gattii in the Age of Whole-Genome Sequencing
por: Meyer, Wieland
Publicado: (2015)

Ploidy-Seq: inferring mutational chronology by sequencing polyploid tumor subpopulations
por: Malhotra, Ankit, et al.
Publicado: (2015)

CanDrA: Cancer-Specific Driver Missense Mutation Annotation with Optimized Features
por: Mao, Yong, et al.
Publicado: (2013)

Genomic Insights Into Sepsis Course Using Whole Exome Sequencing
por: Flores, Carlos, et al.
Publicado: (2016)

Prevalence of actionable mutations and copy number alterations and the price of a genomic testing panel
por: Shen, Chan, et al.
Publicado: (2016)

The rapamycin-regulated gene expression signature determines prognosis for breast cancer
por: Akcakanat, Argun, et al.
Publicado: (2009)

Clonal Evolution in Breast Cancer Revealed by Single Nucleus Genome Sequencing
por: Wang, Yong, et al.
Publicado: (2014)

Adapting a Natural Language Processing Tool to Facilitate Clinical Trial Curation for Personalized Cancer Therapy
por: Zeng, Jia, et al.
Publicado: (2014)

Hotspot mutations delineating diverse mutational signatures and biological utilities across cancer types
por: Chen, Tenghui, et al.
Publicado: (2016)

Whole-genome sequencing: identification of additional pathogenic variation across the genome
por: Mills, James Dominic, et al.
Publicado: (2021)

Maternal plasma sequencing: a powerful tool towards fetal whole genome recovery
por: Papageorgiou, Elisavet A, et al.
Publicado: (2013)

Improving Exploitation of Whole Genome Sequencing Data for Public Health, Forensic Microbiology and Biosafety
por: Pilo, Paola
Publicado: (2015)

Now Is the Time to Implement Whole Genome Sequencing in the Global Antimicrobial Resistance Surveillance for Neisseria gonorrhoeae?
por: Golparian, Daniel, et al.
Publicado: (2019)

Will whole-genome sequencing become the first-line genetic analysis for male infertility in the near future?
por: Ghieh, Farah, et al.
Publicado: (2021)

mSphere of Influence: Whole-Genome Sequencing, a Vital Tool for the Interruption of Nosocomial Transmission
por: Babiker, Ahmed
Publicado: (2021)

FGFR1β is a driver isoform of FGFR1 alternative splicing in breast cancer cells
por: Zhao, Ming, et al.
Publicado: (2019)

Correction: FGFR1β is a driver isoform of FGFR1 alternative splicing in breast cancer cells
por: Zhao, Ming, et al.
Publicado: (2019)

Antibody-drug conjugates in lung cancer: dawn of a new era?
por: Coleman, Niamh, et al.
Publicado: (2023)

Nanogrid single-nucleus RNA sequencing reveals phenotypic diversity in breast cancer
por: Gao, Ruli, et al.
Publicado: (2017)

Use of a Targeted Exome Next-Generation Sequencing Panel Offers Therapeutic Opportunity and Clinical Benefit in a Subset of Patients With Advanced Cancers
por: Kopetz, Scott, et al.
Publicado: (2019)

Efficacy of Quality Criteria to Identify Potentially Harmful Information: A Cross-sectional Survey of Complementary and Alternative Medicine Web Sites
por: Walji, Muhammad, et al.
Publicado: (2004)

Cross-sectional Whole-genome Sequencing and Epidemiological Study of Multidrug-resistant Mycobacterium tuberculosis in China
por: Huang, Hairong, et al.
Publicado: (2019)

Will we cure cancer by sequencing thousands of genomes?
por: Nicholson, Joshua M
Publicado: (2013)

Challenges and perspective of drug repurposing strategies in early phase clinical trials
por: Kato, Shumei, et al.
Publicado: (2015)

Whole slide imaging for teleconsultation and clinical use
por: Dangott, Bryan, et al.
Publicado: (2010)

Cancer driver mutation prediction through Bayesian integration of multi-omic data
por: Wang, Zixing, et al.
Publicado: (2018)

Genomic sequencing in oncology: Considerations for integration in routine cancer care
por: Rahman, Belinda, et al.
Publicado: (2022)

Clinical cancer genomic profiling by three-platform sequencing of whole genome, whole exome and transcriptome
por: Rusch, Michael, et al.
Publicado: (2018)

Trio sequencing in pediatric cancer and clinical implications
por: Kuhlen, Michaela, et al.
Publicado: (2018)

A Phase II Clinical Trial of Pembrolizumab Efficacy and Safety in Advanced Renal Medullary Carcinoma
por: Nze, Chijioke, et al.
Publicado: (2023)

Coordinated prophylactic surgical management for women with hereditary breast-ovarian cancer syndrome
por: Batista, Larissa I, et al.
Publicado: (2008)

A feasibility study of returning clinically actionable somatic genomic alterations identified in a research laboratory
por: Arango, Natalia Paez, et al.
Publicado: (2017)

Collaboration between Clinical and Academic Laboratories for Sequencing SARS-CoV-2 Genomes
por: Wang, Jeremy, et al.
Publicado: (2022)

Comprehensive analysis of long non-coding RNAs in human breast cancer clinical subtypes
por: Su, Xiaoping, et al.
Publicado: (2014)

Correction: A feasibility study of returning clinically actionable somatic genomic alterations identified in a research laboratory
por: Arango, Natalia Paez, et al.
Publicado: (2019)

CombPDX: a unified statistical framework for evaluating drug synergism in patient-derived xenografts
por: Huang, Licai, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_fnq378ntjg46i0823s7e22clue